https://www.selleckchem.com/pr....oducts/olcegepant.ht
In patients with a relapse of MN, the ChLIA allowed an earlier detection of PLA R1-ab recurrence by at least 3 months in 63% of cases compared with the ELISA. The PLA R1-ab ChLIA had the same excellent diagnostic performance as the RC-IFA and outperformed the ELISA in the diagnosis of MN and the early identification of relapses. It thus presents a favorable tool for accurate PLA R1-ab assessment in routine diagnostic settings, while enabling fast processing and fully automated random-access implementation. The PLA2R1-ab ChLIA had the
Beğen
Yorum Yap
Paylaş
